Literature DB >> 22002865

Xeno-free proliferation of human bone marrow mesenchymal stem cells.

Hiroto Miwa1, Yoshiki Hashimoto, Keiji Tensho, Shigeyuki Wakitani, Mutsumi Takagi.   

Abstract

The proliferation of human bone marrow mesenchymal stem cells (MSCs) employing xeno-free materials not containing fetal calf serum (FCS) and porcine trypsin was investigated for the regenerative medicine of cartilage using MSCs. Four sequential subcultivations of MSCs using a medium containing 10% FCS and recombinant trypsin (TrypLESelect™) resulted in cell growth comparable to that with porcine trypsin. There was no apparent difference in the cell growth and morphology between two kinds of MSC stored in liquid nitrogen using 10% FCS plus DMSO or serum-free TC protector™. MSCs were isolated from human bone marrow cells, stored in liquid nitrogen, and sequentially subcultivated four times employing conventional materials that included FCS, porcine trypsin, and DMSO, or xeno-free materials that included serum-free medium (MesenCult-XF™), TC protector™ and TrypLESelect™. Cells in the culture using the xeno-free materials maintained typical fibroblast-like morphology and grew more rapidly than the cells in the culture using the conventional materials, while the cell surface markers of MSCs (CD90 and CD166) were well maintained in both cultures. Chondrogenic pellet cultures were carried out using these subcultivated cells and a medium containing TGFβ3 and IGF1. The pellet culture using cells grown with the xeno-free materials showed an apparently higher gene expression of aggrecan, a chondrocyte marker, than the pellet culture using cells grown with the conventional materials. Consequently, MSCs that are isolated, stored, and grown using the xeno-free materials including the serum-free medium (MesenCult-XF™), TC protector™, and recombinant trypsin (TrypLESelect™) might be applicable for regenerative medicine of cartilage.

Entities:  

Year:  2011        PMID: 22002865      PMCID: PMC3386392          DOI: 10.1007/s10616-011-9400-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  24 in total

1.  Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse.

Authors:  J E Dennis; A I Caplan
Journal:  J Cell Physiol       Date:  1996-06       Impact factor: 6.384

2.  Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.

Authors:  S P Bruder; N Jaiswal; S E Haynesworth
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

3.  Fetal calf serum-free culture of Chinese hamster ovary cells employing fish serum.

Authors:  M Fujiwara; R Tsukada; Y Tsujinaga; M Takagi
Journal:  Appl Microbiol Biotechnol       Date:  2007-03-03       Impact factor: 4.813

4.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.

Authors:  H M Lazarus; S E Haynesworth; S L Gerson; N S Rosenthal; A I Caplan
Journal:  Bone Marrow Transplant       Date:  1995-10       Impact factor: 5.483

5.  Multiplication of Swiss 3T3 cells in a serum-free medium.

Authors:  G D Shipley; R G Ham
Journal:  Exp Cell Res       Date:  1983-07       Impact factor: 3.905

6.  Effects of heat treatment and concentration of fish serum on cell growth in adhesion culture of Chinese hamster ovary cells.

Authors:  Masashi Fujiwara; Ryohei Tsukada; Itaru Shioya; Mutsumi Takagi
Journal:  Cytotechnology       Date:  2009-05-30       Impact factor: 2.058

7.  Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair.

Authors:  R G Young; D L Butler; W Weber; A I Caplan; S L Gordon; D J Fink
Journal:  J Orthop Res       Date:  1998-07       Impact factor: 3.494

8.  Serum supplements and serum-free media: applicability for microcarrier culture of animal cells.

Authors:  J M Clark; C Gebb; M D Hirtenstein
Journal:  Dev Biol Stand       Date:  1981

9.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

10.  Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation.

Authors:  Fumio Arai; Osamu Ohneda; Takeshi Miyamoto; Xiu Qin Zhang; Toshio Suda
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  15 in total

Review 1.  Serum-free media for the production of human mesenchymal stromal cells: a review.

Authors:  S Gottipamula; M S Muttigi; U Kolkundkar; R N Seetharam
Journal:  Cell Prolif       Date:  2013-09-30       Impact factor: 6.831

2.  Evaluation of Serum-Free, Xeno-Free Cryopreservation Solutions for Human Adipose-Derived Mesenchymal Stem Cells.

Authors:  Chika Miyagi-Shiohira; Naoya Kobayashi; Issei Saitoh; Masami Watanabe; Yasufumi Noguchi; Masayuki Matsushita; Hirofumi Noguchi
Journal:  Cell Med       Date:  2016-09-01

3.  Xeno-free chondrogenesis of bone marrow mesenchymal stromal cells: towards clinical-grade chondrocyte production.

Authors:  Maria Skog; Virpi Muhonen; Johanna Nystedt; Roberto Narcisi; Leena-Stiina Kontturi; Arto Urtti; Matti Korhonen; Gerjo J V M van Osch; Ilkka Kiviranta
Journal:  Cytotechnology       Date:  2014-04-10       Impact factor: 2.058

4.  Customized hydrogel substrates for serum-free expansion of functional hMSCs.

Authors:  Ngoc Nhi T Le; Tianran Leona Liu; James Johnston; John D Krutty; Kayla Marie Templeton; Victoria Harms; Andrew Dias; Hau Le; Padma Gopalan; William L Murphy
Journal:  Biomater Sci       Date:  2020-06-16       Impact factor: 6.843

5.  An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers.

Authors:  Naoki Morimoto; Tatsuya Ito; Satoru Takemoto; Mikiko Katakami; Norikazu Kanda; Harue Tada; Shiro Tanaka; Satoshi Teramukai; Katsuya Kawai; Yoko Nakamura; Yasunari Kasai; Yokode Masayuki; Taira Maekawa; Akira Shimizu; Shigehiko Suzuki
Journal:  Int Wound J       Date:  2012-09-07       Impact factor: 3.315

6.  Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.

Authors:  Sunghoon Jung; Krishna M Panchalingam; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cells Int       Date:  2012-05-07       Impact factor: 5.443

7.  Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.

Authors:  José M Díez; Ewa Bauman; Rodrigo Gajardo; Juan I Jorquera
Journal:  Stem Cell Res Ther       Date:  2015-03-13       Impact factor: 6.832

Review 8.  Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review.

Authors:  Krishna M Panchalingam; Sunghoon Jung; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cell Res Ther       Date:  2015-11-23       Impact factor: 6.832

9.  Different culture media affect growth characteristics, surface marker distribution and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells.

Authors:  Sebastien Hagmann; Babak Moradi; Sebastian Frank; Thomas Dreher; Peer Wolfgang Kämmerer; Wiltrud Richter; Tobias Gotterbarm
Journal:  BMC Musculoskelet Disord       Date:  2013-07-30       Impact factor: 2.362

10.  Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.

Authors:  Maria Cristina Corotchi; Mirel Adrian Popa; Anca Remes; Livia Elena Sima; Ilinca Gussi; Marilena Lupu Plesu
Journal:  Stem Cell Res Ther       Date:  2013-07-11       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.